CereVasc

United States · Healthtech · Enterprise software

Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series C$85MBain Capital Life Sciences — Role not disclosedJohnson & Johnson Innovation – JJDC — Role not disclosedMedtronic — Role not disclosedPerceptive Xontogeny Venture Funds — Role not disclosedPiper Sandler Merchant Banking — Role not disclosed
Sourcescerevasc.com ↗